Thymosin Beta-4 a/T Polymorphism and Acute Coronary Syndrome Risk

ARCHIVES OF CLINICAL AND EXPERIMENTAL MEDICINE
doi 10.25000/acem.475094
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Archives of Clinical and Experimental Medicine

Related search

Thymosin Beta 4: A Ubiquitous Peptide in Rat and Mouse Tissues.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1982English

Association of Endothelial Nitric Oxide Synthase Promoter Region (T-786c) Gene Polymorphism With Acute Coronary Syndrome and Coronary Heart Disease

Lipids in Health and Disease
BiochemistryEndocrinologyClinical BiochemistryMetabolismDiabetes
2008English

IRAK-4 Variants in Acute Coronary Syndrome Patients

Anatolian journal of cardiology
Cardiovascular MedicineCardiology
2017English

Metabolic Risk Factors and Outcomes in Acute Coronary Syndrome

Journal of Advances in Medicine and Medical Research
2020English

PWE-158 Thymosin Beta 4 as a Putative Marker in Neuroendocrine Tumours

Gut
Gastroenterology
2013English

Regional Aspects of the Gene Polymorphism Vеgfr2 With Coronary Atherosclerosis in Acute Coronary Syndrome

Russian Journal of Cardiology
Cardiovascular MedicineCardiology
2017English

Acute Coronary Syndrome

Russian Family Doctor
2017English

Acute Coronary Syndrome

Cardiologia Croatica
Cardiovascular MedicineCardiology
2020English

Thymosin Beta-4 and Ciprofloxacin Adjunctive Therapy Improves Pseudomonas Aeruginosa-Induced Keratitis

Cells
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy